Division of Infectious Diseases, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20889, USA.
J Clin Microbiol. 2011 Jan;49(1):159-66. doi: 10.1128/JCM.00766-10. Epub 2010 Nov 17.
The epidemiology of Acinetobacter baumannii emerging in combat casualties is poorly understood. We analyzed 65 (54 nonreplicate) Acinetobacter isolates from 48 patients (46 hospitalized and 2 outpatient trainees entering the military) from October 2004 to October 2005 for genotypic similarities, time-space relatedness, and antibiotic susceptibility. Clinical and surveillance cultures were compared by amplified fragment length polymorphism (AFLP) genomic fingerprinting to each other and to strains of a reference database. Antibiotic susceptibility was determined, and multiplex PCR was performed for OXA-23-like, -24-like, -51-like, and -58-like carbapenemases. Records were reviewed for overlapping hospital stays of the most frequent genotypes, and risk ratios were calculated for any association of genotype with severity of Acute Physiology and Chronic Health Evaluation II (APACHE II) score or injury severity score (ISS) and previous antibiotic use. Nineteen genotypes were identified; two predominated, one consistent with an emerging novel international clone and the other unique to our database. Both predominant genotypes were carbapenem resistant, were present at another hospital before patients' admission to our facility, and were associated with higher APACHE II scores, higher ISSs, and previous carbapenem antibiotics in comparison with other genotypes. One predominated in wound and respiratory isolates, and the other predominated in wound and skin surveillance samples. Several other genotypes were identified as European clones I to III. Acinetobacter genotypes from recruits upon entry to the military, unlike those in hospitalized patients, did not include carbapenem-resistant genotypes. Acinetobacter species isolated from battlefield casualties are diverse, including genotypes belonging to European clones I to III. Two carbapenem-resistant genotypes were epidemic, one of which appeared to belong to a novel international clone.
战场上伤员分离出的鲍曼不动杆菌的流行病学情况还不太清楚。我们分析了 2004 年 10 月至 2005 年 10 月期间 48 名患者(46 名住院患者和 2 名接受军事训练的门诊患者)的 65 株(54 株非重复)鲍曼不动杆菌,以了解基因型的相似性、时间和空间的关联性以及抗生素的敏感性。临床和监测培养物通过扩增片段长度多态性(AFLP)基因组指纹图谱与彼此以及参考数据库中的菌株进行比较。药敏试验采用 OXA-23 样、-24 样、-51 样和 -58 样碳青霉烯酶的多重 PCR 进行。分析了最常见基因型患者重叠住院记录,并计算了基因型与急性生理学和慢性健康评估 II(APACHE II)评分或损伤严重程度评分(ISS)严重程度以及先前抗生素使用的任何关联的风险比。鉴定了 19 种基因型,两种占优势,一种与新兴的国际克隆一致,另一种仅存在于我们的数据库中。两种主要基因型均对碳青霉烯类药物耐药,在患者入院前存在于另一家医院,与其他基因型相比,APACHE II 评分更高、ISS 更高以及先前使用过碳青霉烯类抗生素。一种主要存在于伤口和呼吸道分离株中,另一种主要存在于伤口和皮肤监测样本中。还有几种其他基因型被鉴定为欧洲克隆 I 至 III。新兵入伍时分离出的不动杆菌基因型与住院患者的基因型不同,不包括碳青霉烯类耐药基因型。从战场上伤员分离出的不动杆菌种类繁多,包括属于欧洲克隆 I 至 III 的基因型。两种碳青霉烯类耐药基因型为流行型,其中一种似乎属于一种新型国际克隆。